A new Deloitte analysis estimates that if the U.S. were to invest in closing gaps in women’s health care — including better disease detection and prevention, plus improved management and treatment of women's health conditions — the investment could not only increase women's health spans by up to 20 years, but it could also create $527 billion in additional potential women's health spending by 2030.
“By increasing focus on proactive, life-stage-aware health interventions to address unmet needs, the health industry may add up to 20 years of healthy lifespan for women,” said Dr. Kulleni Gebreyes, MD, principal, vice chair, and U.S. life sciences and health care industry leader at Deloitte. “This transition supports the potential for improved clinical outcomes across a lifetime, greater economic vitality across the broader healthcare ecosystem, and enhanced quality of life for patients."
